Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 65862-022

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 65862-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablet Bottle))

Label for Mirtazapine Orally Disintegrating Tablets USP, 15 mg, by Aurobindo Pharma Limited. The label states the product is for once-a-day use, available as a 30-tablet bottle. It includes instructions about phenylketonurics content, storage conditions, usage, and distribution by Aurobindo Pharma USA, Inc. Made in India, the label shows NDC 65862-021-30 with a barcode.*

FDA Label Image

Package Label-principal Display Panel – 15 mg Blister Carton (5 X 6 Unit-dose) (Mirtazapine Fig2)

Packaging label for Mirtazapine Orally Disintegrating Tablets, USP 15 mg by Aurobindo Pharma Limited. The unit-dose carton contains 5 x 6 tablets. The label includes storage instructions, child-resistant packaging notice, phenylketonurics warning, distribution by Aurobindo Pharma USA, and illustrated instructions for tablet removal.*

FDA Label Image

Package Label-principal Display Panel (30 mg (30 Tablet Bottle))

Label for Mirtazapine Orally Disintegrating Tablets, USP 30 mg, containing 30 tablets. The label indicates the product is for once-a-day use and includes a warning for phenylketonurics about phenylalanine content. It provides storage instructions, dosing reminders, and distribution information by Aurobindo Pharma USA, Inc., with manufacturing in India by Aurobindo Pharma Limited. The label also features the NDC 65862-022-30 and cautions to dispense with a medication guide.*

FDA Label Image

Package Label-principal Display Panel – 30 mg Blister Carton (5 X 6 Unit-dose) (Mirtazapine Fig4)

Packaging label for Mirtazapine Orally Disintegrating Tablets USP 30 mg by Aurobindo Pharma Limited. The label indicates a 5 x 6 unit dose tablet carton with instructions for pharmacists to dispense with medication guide. It includes storage instructions, phenylalanine warning, and illustrated directions for removing tablets from the blister pack. The label also displays the NDC 65862-022-06 and distribution information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (45 mg (30 Tablet Bottle))

Label for Mirtazapine Orally Disintegrating Tablets, USP 45 mg, presented for 30 tablets. The label indicates the product is once-a-day and distributed by Aurobindo Pharma USA, Inc. It includes storage, handling, and dosage instruction notes, as well as a barcode and NDC 65862-023-30. The tablets are manufactured by Aurobindo Pharma Limited and the label specifies the presence of phenylalanine.*

FDA Label Image

Package Label-principal Display Panel – 45 mg Blister Carton (5 X 6 Unit-dose) (Mirtazapine Fig6)

Packaging label for Mirtazapine Orally Disintegrating Tablets USP 45 mg, a once-a-day dosage form. The label indicates the product is Rx only and distributed by Aurobindo Pharma USA, Inc. It includes a 5 x 6 unit dose tablets carton. Instructions for tablet removal and storage information are printed, along with a barcode and the NDC 65862-023-06.*

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical structure of mirtazapine, showing a tricyclic ring system with nitrogen atoms and a methyl substituent on a nitrogen-containing ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.